# OVHIPEC-2 (NCT03772028)

> Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

No report yet. It can be ordered.

- Drugs tested: cisplatin
- Indication: FIGO stage III epithelial ovarian cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03772028
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: The Netherlands Cancer Institute
- Conditions: Ovarian Cancer
- Interventions: cisplatin
- Enrollment: 538
- Primary outcome: overall survival

## Indexed commentary on OVHIPEC-2 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 2 podcast episodes
- 2 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=ovhipec-2-nct03772028